Skip to main content
. 2021 Feb 23;23(2):e18524. doi: 10.2196/18524

Table 4.

Adherence scores per trial group at baseline and follow-up, and the unadjusted per-protocol analyses for primary and secondary outcomes.

Treatment behavior Adherence scores in the intervention group, mean (SD) Adherence scores in the control group, mean (SD) Cohen d (95% CI) t test (df) P value

Baseline Follow-up n (%) Baseline Follow-up n (%)


Overall adherence N/Aa N/A 111 (47.4) N/A N/A 177 (72.5) 0.24 (0.005 to 0.481) 2.006 (286) .046
OHAb score 13.4 (3.4) 14.3 (3.6) 103 (44.0) 13.1 (3.8) 13.4 (3.6) 163 (66.8) 0.18 (−0.070 to 0.423) 1.407 (264) .16
ITc score 7.4 (1.8) 8.0 (1.6) 43 (18.4) 7.7 (1.7) 7.9 (1.7) 68 (27.9) 0.28 (−0.102 to 0.658) 1.453 (109) .15
PAd levele 865 (1141) 833 (741) 111 (47.4) 789 (769) 884 (777) 177 (72.5) −0.07 (−0.265 to 0.130) −0.675 (286) .50
Snack intakef 1857 (1330) 1269 (1182) 111 (47.4) 1656 (1331) 1496 (1108) 177 (72.5) 0.38 (0.098 to 0.661) 2.655 (286) .009

aN/A: not applicable.

bOHA: oral hypoglycemic agent.

cIT: insulin therapy.

dPA: physical activity.

eAverage number of minutes per week.

fAverage number of calories per week.